CANCELLED - SECTION 8
section 8
on 23 Aug 2019
Last Applicant/ Owned by
The Oxford Science Park
Oxford
GB
OX4 4GA
Serial Number
78260879 filed on 11th Jun 2003
Registration Number
3372819 registered on 22nd Jan 2008
Filing Basis
1. intent to use
Disclaimer
NO DATA
RETINOSTAT
Scientific and medical research and development; [ engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; ] advisory services relating to the research and development of gene therapy; consultation services in the fields of medical and scientific research in the field Read More
Classification Information
Class [001]
Chemical Products
Chemical and biochemical products for use in gene delivery technology, namely, enzymes; chemical products for in-vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
Class [005]
Pharmaceutical Products
Gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of [ blood disorders, cancers, diseases of the nervous system, ] macular degeneration, diabetic retinopathy, [ diabetes, inflammatory and auto-immune diseases, vascular disorders, ] disorders arising from improper vascularisation and single gene disorders; pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies, vector production technologies and neurogenomics products; chemical products for use in medical science, particularly for treatment of disease of the eye, vascular and neovascularisation disorders and retinopathy; pharmaceutical and biochemical preparations for the treatment of macular degeneration and retinopathy [ and angiogenesis; ] instruments and apparatus for the administration of gene and [ antibody-based ] therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes
Class [042]
Computer & Software Services & Scientific Services
Scientific and medical research and development; [ engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; ] advisory services relating to the research and development of gene therapy; consultation services in the fields of medical and scientific research in the field of professional gene therapy [; medical research and development in the field of vector production technologies ]
Mark Details
Serial Number
No 78260879
Mark Type
No Service Mark
Attorney Docket Number
No KILB.00015.T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Aug 2019 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| 23rd Mar 2017 | REGISTERED - SEC. 7 REQUEST ABANDONED |
| 22nd Jan 2017 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 14th Mar 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 14th Mar 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 04th Mar 2014 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 04th Mar 2014 | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED |
| 28th Feb 2014 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 27th Feb 2014 | REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD |
| 26th Feb 2014 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |